I currently serve as CEO of Sirtex Medical. My focus is on fostering innovation, cultivating a high-performing team, and accelerating growth, while advancing the Sirtex mission to improve the quality and longevity of patients’ lives.I achieve results by building robust strategic plans, establishing strong customer relationships, and creating a compelling shared vision. I operate with a solutions-oriented, data-driven, inclusive, and collaborative leadership style. Prior to Sirtex, I worked for almost two decades at Abbott Vascular as the company launched an innovative portfolio of Drug-Eluting Stent (DES) products. Highlights during this time include: - Managing global marketing for DES launches in the US, Europe, China, Japan, India, and Latin America - supporting Abbott’s current global DES leadership position. - As Japan Marketing Director, I was awarded the President’s award for achieving an all-time global record for DES market share. As President of Abbott Vascular Japan, I led the market development and launch preparation for Abbott’s revolutionary fully bioabsorbable polymer drug-eluting scaffold. I worked closely with Abbott Clin/reg teams, regulatory agencies, and physician advisors to develop and implement regulatory, clinical, and reimbursement strategies. The product was approved ahead of schedule and received premium reimbursement – the only market worldwide to achieve a premium. I also led the integration of St. Jude Medical Japan with Abbott Vascular Japan and assumed leadership of the combined organization. As part of this re-organization, I initiated several programs to accelerate the growth of the legacy St. Jude Medical portfolio, including developing a dedicated sales organization focused solely on imaging and physiology. These programs and the new sales structure drove significant growth that exceeded expectations in the first 12 months post-acquisition. As DVP for US Coronary Sales & Marketing, I recently spearheaded the market development for coronary microvascular disease (CMD) diagnosis with the launch of the first-ever commercial technology to diagnose CMD in the US. This new technology is now becoming widely available to patients in leading hospitals across the US. AREAS OF EXPERTISE: Setting Vision & Strategy | Product Launch & Go-To-Market Strategies | Staff Training & Development | Sales & Marketing Strategy | Business Analytics | Commercial Excellence | Talent Development | Global Markets | Strategic Planning | Team Leadership | Culture Building | Communication | Medical Device Sales